Hughes D C, Mueller T, Klinger H. "一种的合成方法" [P]. US Patent, US 10675959 B2, 2019-07-26.
Jørgensen K, Martínez F, Kowalski A. "Method for the Synthesis of 1-(3-Methylisoxazol-5-yl)imidazolidin-2-one" [P]. European Patent, EP 3204771 A1, 2021-08-27.
发明人孙丽萍,钱学锋,罗永刚. "A Process for Preparing High-Purity 1-(3-Methylisoxazol-5-yl)imidazolidin-2-one" [P]. 中国发明专利, 专利号 CN 110375575 B, 授权公告日 2024-10-04.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2018, 1353, (4), 162-175.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2011, 902, (10), 8440-8464.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-Methylisoxazol-5-yl)imidazolidin-2-one Using HRMS and NMR". Anal. Chim. Acta, 2014, 797, (6), 6814-6832.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2012, 1701, (8), 1527-1557.